These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2997350)

  • 1. A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.
    Okazaki N; Yoshino M; Yoshida T; Hijikata A
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):556-61. PubMed ID: 2997350
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
    Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Futraful therapy on liver cancer.
    Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Ariyama J
    Clin Oncol; 1977 Mar; 3(1):33-49. PubMed ID: 193664
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.
    Yau T; Chan P; Pang R; Ng K; Fan ST; Poon RT
    Cancer; 2010 Nov; 116(21):5022-9. PubMed ID: 20629034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
    Kudo K; Arakawa A; Takagi Y; Nishimura R; Yamashita Y; Takahashi M
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):747-50. PubMed ID: 9571975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Tsurumachi T; Yamamoto H; Watanabe K; Honda I; Watanabe S; Yamada S; Jingu K; Satomi D; Fujita M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):631-4. PubMed ID: 8678524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1984; 8(8-9):679-80. PubMed ID: 6092187
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of primary hepatoma with marked reduction of the tumor after oral administration of tegafur].
    Kitamura T; Maruyama T; Shigehira M; Ishizaki J; Hayashi K; Nakamura H; Tsuda K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):349-52. PubMed ID: 2829747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin therapy in American patients with hepatocellular carcinoma.
    Ihde DC; Kane RC; Cohen MH; McIntire KR; Minna JD
    Cancer Treat Rep; 1977 Oct; 61(7):1385-7. PubMed ID: 201380
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Asano N; Fukano M; Kubo M; Sato J; Ito A; Inoue T; Tsujikawa T; Ando A; Sasaki M; Yoshioka U; Koyama S; Fujiyama Y; Bamba T
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1069-73. PubMed ID: 9644322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma response to low-dose oral tegafur.
    Shindo K; Mizuno T; Miyakawa K
    DICP; 1991 Sep; 25(9):1009. PubMed ID: 1659043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic chemotherapy of hepatocellular carcinoma].
    Okazaki N; Yoshino M; Yoshida T; Hizikata A; Hasegawa H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1584-8. PubMed ID: 3015033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.
    Ravry MJ; Omura GA; Bartolucci AA
    Cancer Treat Rep; 1984 Dec; 68(12):1517-8. PubMed ID: 6210143
    [No Abstract]   [Full Text] [Related]  

  • 14. An autopsy case of multilocular cystic hepatocellular carcinoma without liver cirrhosis.
    Nagano K; Fukuda Y; Nakano I; Katano Y; Toyoda H; Ebata M; Morita K; Yokozaki S; Takeuchi M; Hayashi K; Hayakawa T
    Hepatogastroenterology; 2000; 47(35):1419-21. PubMed ID: 11100365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.
    Schmidinger M; Wenzel C; Locker GJ; Muehlbacher F; Steininger R; Gnant M; Crevenna R; Budinsky AC
    Br J Cancer; 2001 Dec; 85(12):1850-2. PubMed ID: 11747325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
    Di Meglio G; Fazio N; Nolè F; Della Vigna P; Lorizzo K; Goldhirsch A; Farris A
    Acta Oncol; 2007; 46(8):1205-6. PubMed ID: 17978934
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
    Chauffert B; Seitz JF; Bedenne L; Renard P; Conroy T; Rougier P
    Gastroenterol Clin Biol; 1991; 15(10):774-5. PubMed ID: 1667769
    [No Abstract]   [Full Text] [Related]  

  • 19. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
    Nagasue N; Yukaya H; Okamura J; Kuroda C; Kubo Y; Hirai K; Tanikawa K; Okita K; Ando K; Tamura K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2786-92. PubMed ID: 3019251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.